Clinical Trials Directory

Trials / Completed

CompletedNCT05805579

Diaphragmatic Echography in COVID-19 Pneumonia

Prognostic Value of Transthoracic Diaphragmatic Echography in COVID-19 Pneumonia Patients With Acute Respiratory Failure

Status
Completed
Phase
Study type
Observational
Enrollment
171 (actual)
Sponsor
Javier Lázaro · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

We hypothesized that diaphragm thickness is concerned in acute respiratory failure of COVID19 patients and its ultrasound measure at the begining of hospitalisation is a good predictor of poor outcome. A prospective observational non intervention study is designed.

Detailed description

To answer our hypothesis we will perform diaphragm ultrasound in the first 24hr hospitalized COVID19 patients. In the ultrasound exploration we will assess diaphragm movility and thickness. We will also assess other clinical, biochemistry and radiological variables. The main outcome we want to analyze is the destination on discharge: home, respiratory intermediate critical unit or exitus.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTDiaphragmatic echographyDiaphragmatic echography

Timeline

Start date
2021-02-01
Primary completion
2021-06-20
Completion
2021-06-20
First posted
2023-04-10
Last updated
2023-04-10

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05805579. Inclusion in this directory is not an endorsement.

Diaphragmatic Echography in COVID-19 Pneumonia (NCT05805579) · Clinical Trials Directory